Regulation of cardiac fatty acids metabolism in transgenic mice overexpressing bovine GH

Journal of Endocrinology

Volumn 201, Issue 3, 2009, Pages 419-427

  Bogazzi, Fausto ^a   Raggi, Francesco ^a   Ultimieri, Federica ^a   Russo, Dania ^a   D'Alessio, Aldo ^a   Manariti, Antonella ^a   Brogioni, Sandra ^a   Manetti, Luca ^a   Martino, Enio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACETYL COENZYME A SYNTHETASE; FATTY ACID BINDING PROTEIN; FATTY ACID TRANSPORTER; GROWTH HORMONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LONG CHAIN ACYL COENZYME A DEHYDROGENASE; MALONYL COENZYME A; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PEGVISOMANT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; FATTY ACID; GROWTH HORMONE, BOVINE;

ACROMEGALY; AGE DISTRIBUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FAT CONTENT; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HEART MUSCLE METABOLISM; HORMONAL REGULATION; INFRARED SPECTROSCOPY; INTRACELLULAR TRANSPORT; MALE; METABOLIC REGULATION; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; TRANSGENIC MOUSE; WESTERN BLOTTING; WILD TYPE; AGING; ANIMAL; C57BL MOUSE; CATTLE; CBA MOUSE; CHEMISTRY; GENETICS; HEART MITOCHONDRION; HEART MUSCLE; LIPID METABOLISM; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; UPREGULATION;

AGING; ANIMALS; CATTLE; FATTY ACIDS; GENE EXPRESSION REGULATION; GROWTH HORMONE; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; MITOCHONDRIA, HEART; MYOCARDIUM; OXIDATION-REDUCTION; PPAR ALPHA; UP-REGULATION;

EID: 67849109998     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0194     Document Type: Article

References (35)

1. Albuquerque MLS, Guedes I, Alcantara P & Moreira SGC 2003 Infrared absorption spectra of Buriti (Mauritia flexuosa L.) oil. Vibrational Spectroscopy 33 127-131.
2. Barger PM, Brandt JM, Leone JC, Weinheimer CJ & Kelly DP 2000 Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth. Journal of Clinical Investigation 105 1723-1730.
3. Barger PM, Browning AC, Garner AN & Kelly DP 2001 p38 Mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response. Journal of Biological Chemistry 276 44495-44501.
4. Bartke A, Chandrashekar V, Turyn D, Steger RW, Debeljuk L, Winters TA, Mattison JA, Danilovich NA, Croson W, Wernsing DR et al. 1999 Effects of growth hormone overexpression and growth hormone resistance on neuroendocrine and reproductive functions in transgenic and knock-out mice. Proceedings of the Society for Experimental Biology and Medicine 222 113-123.
5. Bogazzi F, Raggi F, Ultimieri F, Russo D, Manariti A, D'Alessio A, Viacava P, Fanelli G, Gasperi M, Bartalena L et al. 2007 Cardiac expression of adenine nucleotide translocase-1 in transgenic mice overexpressing bovine GH. Journal of Endocrinology 194 521-527.
6. Bogazzi F, Russo D, Raggi F, Ultimieri F, Urbani C, Gasperi M, Bartalena L & Martino E 2008a Transgenic mice overexpressing growth hormone (GH) have reduced or increased cardiac apoptosis through activation of multiple GH-dependent or -independent cell death pathways. Endocrinology 149 5758-5769.
7. Bogazzi F, Lombardi M, Strata E, Aquaro G, Di Bello V, Cosci C, Sardella C, Talini E & Martino E 2008b High prevalence of cardiac hypertophy without detectable signs of fibrosis in patients with untreated active acromegaly: an in vivo study using magnetic resonance imaging. Clinical Endocrinology 68 361-368.
8. Bohlooly YM, Carlson L, Olsson B, Gustafsson H, Andersson IJ, Tornell J & Bergstrom G 2001 Vascular function and blood pressure in GH transgenic mice. Endocrinology 142 3317-3323.
9. Bollano E, Omerovic E, Bohlooly-y M, Kujacic V, Madhu B, Tornell J, Isaksson O, Soussi B, Schulze W, Fu MLX et al. 2000 Impairment of cardiac function and bioenergetics in adult transgenic mice overexpressing the bovine growth hormone gene. Endocrinology 141 2229-2235.
10. Campbell FM, Kozak R, Wagner A, Altarejos JY, Dyck JRB, Belke DD, Severson DL, Kelly DP & Lopaschuk GD 2002 A role for PPARα in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARα are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase. Journal of Biological Chemistry 277 4098-4103.
11. Ciulla M, Arosio M, Barelli MV, Paliotti R, Porretti S, Valentini P, Tortora G, Buonamici V, Moraschi A, Capiello V et al. 1999 Blood pressure-independent cardiac hypertrophy in acromegalic patients. Journal of Hypertension 17 1965-1969.
12. Colao A, Ferone D, Marzullo P & Lombardi G 2004 Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrine Reviews 25 102-152.
13. D'Alessio A, Bramanti E, Piperno M, Naccarato G, Vergamini P & Fornaciari G 2005 A 8500 year-old bladder stone from Uzzo Cave (Trapani): Fourier transform infrared spectroscopy analysis. Archaeometry 47 125-132.
14. Depre C, Shipley GL, Chen W, Han Q, Doenst T, Moore ML, Stepkowski S, Davies P & Taegtmeyer H 1998 Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nature Medicine 4 1269-1275.
15. Desvergne B, Michalik L & Wahli W 2006 Transcriptional regulation of metabolism. Physiological Reviews 86 465-514.
16. Djouadi F, Brandt J, Weinheimer CJ, Leone TC, Gonzalez FJ & Kelly DP 1999 The role of the peroxisome proliferator-activated receptor a (PPARα) in the control of cardiac lipid metabolism. Prostaglandins, Leukotrienes and Essential Fatty Acids 60 339-343.
17. Fazio S, Cittadini A, Cuocolo A, Merola B, Sabatini D, Colao A, Biondi B, Lombardi G & Saccà L 1994 Impaired cardiac performance is a distinct feature of uncomplicated acromegaly. Journal of Clinical Endocrinology and Metabolism 79 441-446.
18. Finck BN 2007 The PPAR regulatory system in cardiac physiology and disease. Cardiovascular Research 73 269-277.
19. Finck B, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, Han X, Gross RW, Kozak R & Lopaschuk GD 2002 The cardiac phenotype induced by PPAR α overexpression mimics that caused by diabetes mellitus. Journal of Clinical Investigation 109 121-130.
20. Fu ML, Tornell J, Schulze W, Hoebeke J, Isaksson OG, Sandstedt J & Hjalmarson A 2000 Myocardial hypertrophy in transgenic mice overexpressing the bovine growth hormone (bGH) gene. Journal of Internal Medicine 247 546-552.
21. Huss JM & Kelly DP 2004 Nuclear receptor signaling and cardiac energetics. Circulation Research 95 568-578.
22. Kodde IF, van der Stok J, Smolenski RT & de Jong JW 2007 Metabolic and genetic regulation of cardiac energy substrate preference. Comparative Biochemistry and Physiology, Part A 146 26-39.
23. Kopchick JJ, Bellush LL & Coschigano KT 1999 Transgenic models of growth hormone action. Annual Review of Nutrition 19 437-461.
24. Lie JT & Grossman SJ 1980 Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. American Heart Journal 1 41-52.
25. Lund DD & Tomanek RJ 1978 Myocardial morphology in spontaneously hypertensive and aortic-constricted rats. American Journal of Anatomy 152 141-152.
26. Melmed S 2006 Acromegaly. New England Journal of Medicine 355 2558-2573.
27. Omerovic E, Basetti M, Bollano E, Bohlooly M, Törnell J, Isgaard J, Hjalmarson Å, Soussi B & Waagstein F 2000 In vivo metabolic imaging of cardiac bioenergetics in transgenic mice. Biochemical and Biophysical Research Communications 29 222-228.
28. Saccà L, Cittadini A & Fazio S 1994 Growth hormone and the heart. Endocrine Reviews 15 555-573.
29. Sack MN, Rader TA, Park S, Bastin J, McCune SA & Kelly DP 1996 Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 94 2837-2842.
30. Shipp JC, Opie LH & Challoner D 1961 Fatty acid and glucose metabolism in the perfused heart. Nature 189 1018-1019.
31. Stanley WC & Chandler MP 2002 Energy metabolism in the normal and failing heart: potential for therapeutic interventions. Heart Failure Reviews 7 115-130.
32. Taegtmeyer H 1994 Energy metabolism of the heart: from basic concepts to clinical applications. Current Problems in Cardiology 19 59-113.
33. Watanabe K, Fujii H, Takahashi T, Kodama M, Aizawa Y, Ohta Y, Ono T, Hasegawa G, Naito M, Nakajima T et al. 2000 Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor a associated with age-dependent. Journal of Biological Chemistry 275 22293-22299.
34. Yamauchi T, Ueki K, Tobe K, Tamemoto H, Sekine N, Wada M, Honjo M, Takahashi M, Takahashi T, Hirai H et al. 1997 Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature 390 91-96.
35. Zhu T, Ling L & Lobie P 2002 Identification of a JAK2-independent pathway regulating growth hormone (GH)-stimulated p44/42 mitogen-activated protein kinase activity (GH) activation of Ral and phospholipase D is src-dependent. Journal of Biological Chemistry 277 45592-45603.